The present invention relates to a method for providing chorion cells as a source of MSCs with cardio-myogenic and angiogenic potential, the use of these cells in clinical treatment, the obtaining of a conditioned medium of chorion-MSCs cells as inducer of angiogenesis and its use in tube-like structures generation and cardiac regeneration as an alternative to bone marrow cells in the treatment of degenerative conditions.